Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$763.98 6.28 (0.83%) as of 4:30 Tue 5/14


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 730.81(B)
Last Volume: 1,955,966 Avg Vol: 3,290,337
52 Week Range: $423.21 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 220,750 870,750 2,710,260 6,211,418
Total Sell Value $171,350,547 $608,250,580 $2,147,483,647 $2,147,483,647
Total People Sold 2 2 5 6
Total Sell Transactions 3 13 42 89
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 1437
  Page 15 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-15 4 S $271.04 $60,511,869 D/D (220,075) 106,633,810 -20%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-14 4 S $269.21 $46,626,915 D/D (173,085) 106,853,885 -22%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-11 4 S $269.05 $5,875,986 D/D (21,840) 107,026,970 -23%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-10 4 S $266.29 $49,287,539 D/D (184,982) 107,048,810 -21%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-09 4 S $266.38 $5,335,148 D/D (20,018) 107,233,792 -24%     
   Lilly Endowment Inc 10% Owner   –       –       •   2022-03-04 4 S $260.69 $55,070,947 D/D (210,000) 107,253,810 -24%     
   Runge Marschall S Director   –       •      –    2022-03-01 4 B $246.78 $49,850 D/D 202 15,436 2.39 33%     
   Jonsson Patrik SVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2022-03-01 4 AS $247.56 $167,103 D/D (675) 32,035 33%     
   Hakim Anat SVP, GC & Secretary   •       –      –    2022-03-01 4 D $249.95 $874,825 D/D (3,500) 8,864     -
   Hakim Anat SVP, GC & Secretary   •       –      –    2022-03-01 4 OE $0.00 $0 D/D 7,929 12,364     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2022-02-25 4 AS $243.84 $404,774 D/D (1,660) 7,274 31%     
   Luciano Juan R Director   –       •      –    2022-02-22 4 A $239.13 $12,674 D/D 53 13,591     -
   Fyrwald J Erik Director   –       •      –    2022-02-22 4 A $239.13 $9,804 D/D 41 68,883     -
   Greene Gabrielle E Director   –       •      –    2022-02-22 4 A $239.13 $9,804 D/D 41 761     -
   Alvarez Ralph Director   –       •      –    2022-02-22 4 A $239.13 $11,239 D/D 47 51,189     -
   Johnson Kimberly H Director   –       •      –    2022-02-22 4 A $239.13 $9,565 D/D 40 1,133     -
   Yuffa Ilya SVP & President, LLY Intl   •       –      –    2022-02-16 4 AS $242.58 $242,580 D/D (1,000) 11,624 29%     
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONC   •       –      –    2022-02-16 4 D $243.84 $533,034 D/D (2,186) 7,967     -
   Van Naarden Jacob SVP, CEO LoxoONC, Pres LlyONC   •       –      –    2022-02-16 4 OE $0.00 $0 D/D 5,461 10,153     -
   Yuffa Ilya SVP & President, LLY Intl   •       –      –    2022-02-15 4 AS $237.45 $237,450 D/D (1,000) 12,624 34%     
   White Anne E. SVP & Pres-Lilly Neuroscience   •       –      –    2022-02-09 4 A $243.27 $2,760,628 D/D 11,348 50,352     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2022-02-09 4 A $243.27 $3,001,709 D/D 12,339 152,631     -
   Jonsson Patrik SVP&Pres, LLY Imm, LLY USA&CCO   •       –      –    2022-02-09 4 A $243.27 $495,298 D/D 2,036 32,710     -
   Pusey Leigh Ann SVP, Corp. Affairs & Comm.   •       –      –    2022-02-09 4 A $243.27 $1,291,520 D/D 5,309 26,244     -
   Hernandez Edgardo SVP & Pres., Mfg. Operations   •       –      –    2022-02-09 4 A $243.27 $1,322,172 D/D 5,435 20,610     -
  1437 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us